Literature DB >> 1500229

Expression of histo-blood-group-A/B-gene-defined glycosyltransferases in normal and malignant epithelia: correlation with A/B-carbohydrate expression.

U Mandel1, N C Langkilde, T F Orntoft, M H Therkildsen, J Karkov, J Reibel, T White, H Clausen, E Dabelsteen.   

Abstract

Malignant transformation of oral and bladder epithelia is often associated with loss of histo-blood-group-A- and -B-carbohydrate antigens, whereas these antigens, which are absent in normal adult distal colon (but present in fetal colon) reappear in malignant distal colon. In order to gain insight into the genetic basis of the biosynthetic regulation for these changes, we have correlated the expression of the A- and B-carbohydrate antigens with that of the A/B-gene-defined glycosyltransferases in colon, bladder and oral carcinomas by immunohistology. A newly developed anti-A/B-transferase monoclonal antibody (MAb) was used to demonstrate the in situ localization of transferase expression at the individual cell level with correlation to carbohydrate antigen expression, and gave the essential information that the transferase is derived from the ABO gene complex. The reappearance of A- and B-carbohydrate antigens in carcinomas of the distal colon was found to be unrelated to the expression of the A/B-transferase proteins, which were expressed throughout normal adult colon in accordance with previous enzymatic studies. In contrast, the loss of A- and B-carbohydrate antigens in malignant bladder and oral epithelia was accompanied by concordant loss of enzymes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500229     DOI: 10.1002/ijc.2910520103

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Protein glycosylation in cancer biology: an overview.

Authors:  F Dall'olio
Journal:  Clin Mol Pathol       Date:  1996-06

2.  Type-1 chain histo-blood group antigens (Le(a), monosialosyl-Le(a), disialosyl-Le(a), Le(b), and H) in normal and malignant human endometrium.

Authors:  V Ravn; U Mandel; B Svenstrup; E Dabelsteen
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

3.  Prognostic Impact of ABO Blood Group on Type I Endometrial Cancer Patients- Results from Our Own and Other Studies.

Authors:  Vincenzo Dario Mandato; Federica Torricelli; Valentina Mastrofilippo; Gino Ciarlini; Debora Pirillo; Enrico Farnetti; Loretta Fornaciari; Bruno Casali; Maria Carolina Gelli; Martino Abrate; Lorenzo Aguzzoli; Giovanni Battista La Sala; Davide Nicoli
Journal:  J Cancer       Date:  2017-08-23       Impact factor: 4.207

4.  Applying transcriptomics to studyglycosylation at the cell type level.

Authors:  Leo Alexander Dworkin; Henrik Clausen; Hiren Jitendra Joshi
Journal:  iScience       Date:  2022-05-18

5.  Classification of Dukes' B and C colorectal cancers using expression arrays.

Authors:  Casper Møller Frederiksen; Steen Knudsen; Søren Laurberg; Torben F Ørntoft
Journal:  J Cancer Res Clin Oncol       Date:  2003-05-15       Impact factor: 4.553

6.  A, B, H, and Lewis-a and Lewis-b blood group antigens in human breast cancer: correlation with steroid hormone receptor and disease status.

Authors:  H A Idikio; V Manickavel
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 7.  Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer.

Authors:  Andréia Vasconcelos-Dos-Santos; Isadora A Oliveira; Miguel Clodomiro Lucena; Natalia Rodrigues Mantuano; Stephen A Whelan; Wagner Barbosa Dias; Adriane Regina Todeschini
Journal:  Front Oncol       Date:  2015-06-25       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.